GW043 as Rapid Antidepressant: Partial Agonist of NMDA Receptors (2024 Study)
GW043 emerges as a promising new compound in the treatment of depression showcasing rapid and significant antidepressant effects by targeting NMDA receptors (NMDARs). This mechanism offers h…
Read article